NO171853C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser

Info

Publication number
NO171853C
NO171853C NO884058A NO884058A NO171853C NO 171853 C NO171853 C NO 171853C NO 884058 A NO884058 A NO 884058A NO 884058 A NO884058 A NO 884058A NO 171853 C NO171853 C NO 171853C
Authority
NO
Norway
Prior art keywords
alcoxyiminoacetamido
pyrazolio
tiazol
7beta
cefem
Prior art date
Application number
NO884058A
Other languages
English (en)
Norwegian (no)
Other versions
NO884058D0 (no
NO171853B (no
NO884058L (no
Inventor
Kazuo Sakane
Kohji Kawabata
Kenzi Miyai
Yoshiko Inamoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721568A external-priority patent/GB8721568D0/en
Priority claimed from GB888815361A external-priority patent/GB8815361D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO884058D0 publication Critical patent/NO884058D0/no
Publication of NO884058L publication Critical patent/NO884058L/no
Publication of NO171853B publication Critical patent/NO171853B/no
Publication of NO171853C publication Critical patent/NO171853C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO884058A 1987-09-14 1988-09-13 Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser NO171853C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878721568A GB8721568D0 (en) 1987-09-14 1987-09-14 Cephem compounds
GB888815361A GB8815361D0 (en) 1988-06-28 1988-06-28 New cephem compound & process for preparation thereof

Publications (4)

Publication Number Publication Date
NO884058D0 NO884058D0 (no) 1988-09-13
NO884058L NO884058L (no) 1989-03-15
NO171853B NO171853B (no) 1993-02-01
NO171853C true NO171853C (no) 1993-05-12

Family

ID=26292732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884058A NO171853C (no) 1987-09-14 1988-09-13 Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser

Country Status (22)

Country Link
US (1) US4952578A (fr)
EP (1) EP0307804B1 (fr)
JP (1) JPH01151589A (fr)
KR (1) KR0133560B1 (fr)
CN (1) CN1024669C (fr)
AU (1) AU617358B2 (fr)
CA (1) CA1338842C (fr)
DE (1) DE3885688T2 (fr)
DK (1) DK509988A (fr)
ES (1) ES2061581T3 (fr)
FI (1) FI92322C (fr)
HK (1) HK18396A (fr)
HU (1) HU211830A9 (fr)
IE (1) IE63094B1 (fr)
IL (1) IL87731A (fr)
NO (1) NO171853C (fr)
NZ (1) NZ226143A (fr)
OA (1) OA09014A (fr)
PH (1) PH24719A (fr)
PT (1) PT88481B (fr)
RU (1) RU1787158C (fr)
UA (1) UA41865C2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194432A (en) * 1985-11-22 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
CA1293719C (fr) * 1986-09-22 1991-12-31 Takao Takaya Composes de cephem et procede de preparation
US5162520A (en) * 1986-09-22 1992-11-10 Fujisawa Pharmaceutical Co., Ltd. Intermediates for cephem compounds
US5663163A (en) * 1987-09-07 1997-09-02 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
GB8905301D0 (en) * 1989-03-08 1989-04-19 Fujisawa Pharmaceutical Co New cephem compound and a process for preparation thereof
EP0517041A1 (fr) * 1991-06-07 1992-12-09 Fujisawa Pharmaceutical Co., Ltd. Dérivés céphem
ES2254671T3 (es) * 2001-05-01 2006-06-16 Astellas Pharma Inc. Compuestos de cefem.
KR100463920B1 (ko) * 2002-10-18 2004-12-30 제일약품주식회사 신규 세프디토렌 피복실 메지틸렌 설폰산염 및 그 제조방법
ES2290498T7 (es) * 2002-10-30 2015-07-10 Astellas Pharma Inc. Compuestos de cefem
AU2003902380A0 (en) * 2003-05-16 2003-06-05 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US7192943B2 (en) * 2003-09-18 2007-03-20 Astellas Pharma Inc. Cephem compounds
CN1321109C (zh) * 2003-11-07 2007-06-13 天津药物研究院 一种头孢烯类鎓盐化合物及其制备方法和以该化合物合成硫酸头孢吡唑的方法
CN101747348B (zh) * 2008-12-11 2013-02-06 石药集团中奇制药技术（石家庄）有限公司 一种硫酸头孢噻利晶型及其制备方法
CN101781318B (zh) * 2010-02-26 2013-07-31 烟台宝华生物技术有限公司 头孢母核衍生化合物、由其制备的头孢烯类鎓盐化合物及采用其制备硫酸头孢吡唑的方法
CN101830913B (zh) * 2010-04-09 2012-10-31 烟台宝华生物技术有限公司 头孢母核衍生化合物、由其制备的头孢烯类鎓盐化合物及采用其制备硫酸头孢吡唑的方法
CN101993450B (zh) * 2010-11-03 2011-11-30 湖南欧亚生物有限公司 一种硫酸头孢噻利的制备方法
CN102336771A (zh) * 2011-07-11 2012-02-01 珠海联邦制药股份有限公司 一种硫酸头孢噻利中间体的制备方法
US20130065874A1 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN102875572B (zh) * 2012-10-26 2014-07-30 四川科伦药物研究有限公司 一种硫酸头孢噻利中间体的精制方法
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
CA2906151A1 (fr) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Compositions antibiotiques de ceftolozane
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (fr) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
GB2037281B (en) * 1978-11-15 1983-01-19 Glaxo Group Ltd 7( -(2-amino-4-thiozolyl)-2-hydroximino-acetanuds)-cephalosporins
ES8306160A1 (es) * 1981-04-03 1983-05-01 Fujisawa Pharmaceutical Co "procedimiento para preparar un nuevo compuesto de cefem".
JPS584789A (ja) * 1981-04-03 1983-01-11 Fujisawa Pharmaceut Co Ltd 新規セフエム化合物およびその製造法
US4401668A (en) * 1981-10-02 1983-08-30 Eli Lilly And Company Pyrazinium substituted cephalosporins
ATE82976T1 (de) * 1985-09-03 1992-12-15 Otsuka Kagaku Kk Cephalosporinderivate.
DE3539901A1 (de) * 1985-11-11 1987-05-14 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
CN86107947A (zh) * 1985-11-22 1987-05-27 藤沢药品工业株式会社 新的头孢烯化合物及其制备方法

Also Published As

Publication number Publication date
FI92322C (fi) 1994-10-25
DE3885688T2 (de) 1994-04-07
CN1032540A (zh) 1989-04-26
HK18396A (en) 1996-02-09
NO884058D0 (no) 1988-09-13
IL87731A0 (en) 1989-02-28
JPH0576950B2 (fr) 1993-10-25
KR890005124A (ko) 1989-05-11
FI92322B (fi) 1994-07-15
EP0307804A2 (fr) 1989-03-22
PH24719A (en) 1990-10-01
HU211830A9 (en) 1995-12-28
IL87731A (en) 1993-05-13
OA09014A (fr) 1991-03-31
PT88481A (pt) 1988-10-01
AU2227188A (en) 1989-03-16
JPH01151589A (ja) 1989-06-14
NO171853B (no) 1993-02-01
IE63094B1 (en) 1995-03-22
DK509988A (da) 1989-03-15
CA1338842C (fr) 1997-01-14
ES2061581T3 (es) 1994-12-16
US4952578A (en) 1990-08-28
EP0307804A3 (en) 1989-11-08
KR0133560B1 (ko) 1998-04-23
FI884193A0 (fi) 1988-09-13
PT88481B (pt) 1992-11-30
DK509988D0 (da) 1988-09-13
AU617358B2 (en) 1991-11-28
IE882692L (en) 1989-03-14
DE3885688D1 (de) 1993-12-23
EP0307804B1 (fr) 1993-11-18
NO884058L (no) 1989-03-15
NZ226143A (en) 1990-11-27
RU1787158C (ru) 1993-01-07
UA41865C2 (uk) 2001-10-15
CN1024669C (zh) 1994-05-25
FI884193A (fi) 1989-03-15

Similar Documents

Publication Publication Date Title
NO171853C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser
NO172048C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazoler
NO169439C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler
NO173238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-beta-(karboksyalkenoylamino)-3-cefem-4-karboksylsyre-forbindelser
NO895086D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO169900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater
NO872946D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO851695L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater
NO167200C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive urinstoff-forbindelser.
NO165397C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO172986C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 9h-puriner
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO169438C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser
NO895170L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 7-oksabicykloheptyl-substituerte heterocyklisk amid-prostaglandinanaloger.
NO172575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
NO883485L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO170582C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO873680L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO171501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO172115C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bronkospasmolytiske forbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MARCH 2003